Single-Lead Percutaneous Peripheral Nerve Stimulation for the Treatment of Shoulder Pain From Subacromial Impingement Syndrome

This case report demonstrates the feasibility of a single-lead peripheral nerve stimulation system for the treatment of pain secondary to chronic subacromial impingement syndrome. The participant was a 57-year-old man who experienced persistent pain from subacromial impingement syndrome for 20 month...

Full description

Saved in:
Bibliographic Details
Published in:PM & R 2012-08, Vol.4 (8), p.624-628
Main Authors: Wilson, Richard D., MD, Harris, Michael A., MD, Bennett, Maria E., MS, Chae, John, MD
Format: Article
Language:English
Subjects:
Accidents, Traffic
Disability Evaluation
Humans
Male
Middle Aged
Pain Measurement
Physical Medicine and Rehabilitation
Quality of Life
Shoulder Impingement Syndrome - complications
Shoulder Pain - etiology
Shoulder Pain - therapy
Transcutaneous Electric Nerve Stimulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This case report demonstrates the feasibility of a single-lead peripheral nerve stimulation system for the treatment of pain secondary to chronic subacromial impingement syndrome. The participant was a 57-year-old man who experienced persistent pain from subacromial impingement syndrome for 20 months despite having undergone conservative therapy of steroid injection and physical therapy. After study enrollment, a single intramuscular lead was placed percutaneously into the deltoid muscle of the affected shoulder. He was treated 6 hours per day for 3 weeks and the lead was removed. The primary outcome measure was the Brief Pain Inventory (Short-form) Question 3 (BPI 3), which queries the worst pain in the last week on a 0-10 numerical rating scale. At baseline, BPI 3 was an 8. At the end of treatment and at 4 and 12 weeks after treatment, BPI 3 scores were 2, 0, and 0, respectively. Substantial improvements in shoulder impairment, quality of life, and shoulder disability measures were also observed. Additional studies are needed to further demonstrate safety and efficacy, determine optimal dose, define optimal prescriptive parameters, expand clinical indications, and demonstrate long-term effect.
ISSN:1934-1482
1934-1563
DOI:10.1016/j.pmrj.2012.03.002